Fresenius Helios is investing €14 million to modernize its hospital in Wipperfürth, North Rhine-Westphalia. Starting late this month, two wards will be completely renovated and expanded, with three delivery rooms to follow. To minimize disruptions to hospital operations, the individual renovations are being carried out in sequence. When completed in early 2019, they will provide more comfort for patients and reduce the distances that need to be walked inside the hospital.

Fresenius Helios is investing €14 million to modernize its hospital in Wipperfürth, North Rhine-Westphalia. Starting late this month, two wards will be completely renovated and expanded, with three delivery rooms to follow. To minimize disruptions to hospital operations, the individual renovations are being carried out in sequence. When completed in early 2019, they will provide more comfort for patients and reduce the distances that need to be walked inside the hospital.

Fitch Ratings has assigned Fresenius Finance Ireland’s €2,600 million notes issued to finance the acquisition of Quirónsalud an instrument rating of BBB-. It also affirmed Fresenius’ corporate credit rating at BBB-. The outlook is stable. The €2,600 million notes were drawn under the newly established Fresenius European Medium Term Note (EMTN) Program and issued by Fresenius Finance Ireland plc., a wholly owned subsidiary of Fresenius SE & Co. KGaA.

Fitch Ratings has assigned Fresenius Finance Ireland’s €2,600 million notes issued to finance the acquisition of Quirónsalud an instrument rating of BBB-. It also affirmed Fresenius’ corporate credit rating at BBB-. The outlook is stable. The €2,600 million notes were drawn under the newly established Fresenius European Medium Term Note (EMTN) Program and issued by Fresenius Finance Ireland plc., a wholly owned subsidiary of Fresenius SE & Co. KGaA.

Fresenius Helios has opened the new building at its hospital in the western German city of Duisburg. The 22,000-square-meter (237,000-square-foot) structure will accommodate up to 350 inpatients. Construction took two years, with Fresenius Helios investing €50 million in the new building. The move from the existing facility into the new building will start later this month.

Quirónsalud, a unit of Fresenius Helios, is investing about €40 million to build a proton beam therapy center in Madrid. Scheduled for opening in 2019, it will be the first facility of this type for treating cancer patients in Spain. Currently, every patient who can benefit from proton beam therapy must seek treatment outside the country. In proton beam therapy, the use of a high-energy beam allows tumors to be irradiated with lower total doses of radiation and reduced exposure to surrounding tissue compared with conventional radiation therapy. Quirónsalud will also modernize and expand its radiotherapy clinics in Palmaplanas (Mallorca) and Seville.